AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...
Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.
In addition to OEM distribution, the collaboration provides flexibility for potential future expansion, which could include Dyadic supplying market-ready products for distribution or licensing ...
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases ...
Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...
Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.
Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (Nasdaq: DYAI), ...
A new review outlines design principles and applications of synthetic membraneless organelles built through liquid-liquid phase separation for use in biotechnology.
When we discuss bacterial infections, we often think of exotoxins—those soluble proteins actively secreted by bacteria—while ...
Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results